GlassScriptPhysician profile
Daniel Joseph Ricchiuti
NPI 1003851833
$7,050.62
in general payments reported to CMS, 2019-2025
49 companies · $1,357 in 2025
The $1,357 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $2,051 · 2021: $650 · 2022: $789 · 2023: $922 · 2024: $676 · 2025: $1,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $213.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,788.00 | 2020 | |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Astellas Pharma US INC | $914.68 | 2019-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $378.53 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $296.70 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $284.00 | 2021-2022 | |
| Janssen Biotech, INC. | $254.57 | 2019-2023 | Erleada |
| Dendreon Pharmaceuticals LLC | $219.05 | 2019-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $151.04 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $123.29 | 2022-2024 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $122.83 | 2022-2025 | |
| Blue Earth Diagnostics | $119.19 | 2020-2022 | |
| Medtronic, INC. | $107.15 | 2021-2024 | V-Loc 180, Swiftset |
| Biotissue Holdings INC. | $84.46 | 2024 | |
| Verity Pharmaceuticals INC. | $81.35 | 2023-2024 | Trelstar |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ricchiuti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.